Jeffrey L. Wade

Insider Reports History

Location
The Woodlands, TX
Signature
/s/ Jeffrey L. Wade
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey L. Wade:

Company Role Class Num Shares Value Price $ Report Date Ownership
LEXICON PHARMACEUTICALS, INC. President and COO Common Stock 324,214 $849,441 $2.62 28 Feb 2024 Direct
LEXICON PHARMACEUTICALS, INC. President and COO Restricted Stock Units 98,227 $257,355 $2.62 28 Feb 2024 Direct
LEXICON PHARMACEUTICALS, INC. President and COO Stock Option (Right to Buy) 307,000 08 Jul 2024 Direct

Insider Reports Filed by Jeffrey L. Wade

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXRX LEXICON PHARMACEUTICALS, INC. 08 Jul 2024 1 $0 4 President and COO 08 Jul 2024, 17:27
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2024 7 -$98,750 4 President and CFO 29 Feb 2024, 16:32
LXRX LEXICON PHARMACEUTICALS, INC. 08 Feb 2024 2 $0 4 President and CFO 12 Feb 2024, 16:18
LXRX LEXICON PHARMACEUTICALS, INC. 14 Sep 2023 1 +$13,800 4 President and CFO 14 Sep 2023, 18:05
LXRX LEXICON PHARMACEUTICALS, INC. 20 Jun 2023 2 +$28,000 4 President and CFO 20 Jun 2023, 16:10
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2023 7 -$65,653 4 President and CFO 01 Mar 2023, 15:48
LXRX LEXICON PHARMACEUTICALS, INC. 09 Feb 2023 2 $0 4 President and CFO 13 Feb 2023, 15:56
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2022 7 -$73,453 4 President and CFO 28 Feb 2022, 18:12
LXRX LEXICON PHARMACEUTICALS, INC. 10 Feb 2022 2 $0 4 President and CFO 14 Feb 2022, 15:08
LXRX LEXICON PHARMACEUTICALS, INC. 31 Dec 2021 1 $0 5 President and CFO 11 Feb 2022, 16:27